| scholarly article | Q13442814 |
| P2093 | author name string | Babbette LaMarca | |
| Mark W Cunningham | |||
| Nathan Campbell | |||
| P2860 | cites work | Preeclampsia: long-term consequences for vascular health | Q26800272 |
| Nitric oxide and reactive oxygen species in the pathogenesis of preeclampsia | Q28083676 | ||
| Inhibition of Angiotensin II receptors during pregnancy induces malformations in developing rat kidney | Q28583780 | ||
| Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension | Q74126541 | ||
| Circulating levels of immunoreactive cytokines in women with preeclampsia | Q77384781 | ||
| The role of angiotensin II type 1 receptor-activating antibodies in renal allograft vascular rejection | Q79882539 | ||
| Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature | Q81423834 | ||
| Hypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertension | Q83799951 | ||
| Autoantibodies isolated from preeclamptic patients induce endothelial dysfunction via interaction with the angiotensin II AT1 receptor | Q86521061 | ||
| The detrimental role of angiotensin receptor agonistic autoantibodies in intrauterine growth restriction seen in preeclampsia | Q33591058 | ||
| The role of inflammation in the pathology of preeclampsia | Q33834419 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats | Q34072217 | ||
| Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy | Q34453242 | ||
| Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy | Q34541831 | ||
| Pregnancy and the risk of stroke | Q34683028 | ||
| Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis | Q34708320 | ||
| Public health perspectives of preeclampsia in developing countries: implication for health system strengthening | Q34919890 | ||
| Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study | Q34950435 | ||
| Maternal treatment with agonistic autoantibodies against type-1 angiotensin II receptor in late pregnancy increases apoptosis of myocardial cells and myocardial susceptibility to ischemia-reperfusion injury in offspring rats | Q35053657 | ||
| Regulation of soluble fms-like tyrosine kinase-1 production in response to placental ischemia/hypoxia: role of angiotensin II. | Q35363716 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation | Q35830416 | ||
| Angiotensin II receptor antagonist treatment during pregnancy | Q36019473 | ||
| Autoantibody-mediated angiotensin receptor activation contributes to preeclampsia through tumor necrosis factor-alpha signaling | Q36050771 | ||
| A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model | Q36115311 | ||
| IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy | Q36178540 | ||
| Preeclampsia: recent insights | Q36288757 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Angiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant rats | Q36683260 | ||
| Angiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertension | Q37353499 | ||
| Endothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancy | Q37353537 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| Role of IgM and angiotensin II Type I receptor autoantibodies in local complement activation in placental ischemia-induced hypertension in the rat. | Q41653771 | ||
| Losartan and fetal toxic effects | Q43531337 | ||
| HELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodies | Q43672726 | ||
| Angiotensin II and cAMP regulate AT(1)-mRNA expression in rat cardiomyocytes by transcriptional mechanism | Q44070519 | ||
| Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension | Q44162378 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia | Q44413491 | ||
| Human fetal malformations associated with the use of an angiotensin II receptor antagonist: case report | Q44787814 | ||
| Preeclampsia and the risk of end-stage renal disease | Q45748808 | ||
| Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion | Q46877931 | ||
| Natural killer cells mediate pathophysiology in response to reduced uterine perfusion pressure | Q47637232 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor | Q73815485 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-eclampsia | Q61335 |
| autoantibody | Q785022 | ||
| pathophysiology | Q1135939 | ||
| P304 | page(s) | 781-785 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Current Pharmaceutical Biotechnology | Q15763083 |
| P1476 | title | The role of Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor (AT1-AA) in Pathophysiology of Preeclampsia | |
| P478 | volume | 19 |
Search more.